Condition: Respiratory Syncytial Virus (RSV) · Sponsor: PENTA Foundation
THAI-CARES RSV Study is a Phase II, open-label, multicenter, randomized controlled trial with a two-arm, parallel-group design. The study aims to assess the safety, efficacy, and acceptability of a five-day course of Remdesivir (VEKLURY®) in children under two years of age who are hospitalized with confirmed respiratory syncytial virus (RSV) infection, as determined by either a rapid antigen test or RT-PCR. The primary objectives include evaluating the treatment's safety profile, its ability to significantly reduce RSV replication, and its overall acceptance in this patient population.
This description comes directly from the study's public registry record.
Federica D'Ambrosio · +39 049 716 9848 · federica.dambrosio@pentafoundation.org
Always discuss trial participation with your own doctor first.
| Center of Excellence for Pediatric Infectious Diseases and Vaccines Faculty of Medicine, Chulalongkorn University (CE-PID) | Bangkok, Thailand | Recruiting |
| Nakornping Hospital | Chiang Mai, Thailand | Recruiting |
| Maharaj Nakorn Chiang Mai Hospital | Chiang Mai, Thailand | Recruiting |
| Chiangrai Prachanukroh Hospital | Chiang Rai, Thailand | Recruiting |
| Khon Kaen Hospital | Khon Kaen, Thailand | Not Yet Recruiting |
| Lampang Hospital | Lampang, Thailand | Recruiting |
| Mahasarakham Hospital | Maha Sarakham, Thailand | Recruiting |
| Samut Sakhon Hospital | Samut Sakhon, Thailand | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06873633